Geron Corporation (BIT:1GERN)
Italy · Delayed Price · Currency is EUR 1.056
+0.084 (8.70%)
At close: Oct 31, 2025
Geron Company Description
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia.
The company was incorporated in 1990 and is headquartered in Foster City, California.
Geron Corporation
| Country | United States |
| Founded | 1990 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 229 |
| CEO | Harout Semerjian |
Contact Details
Address: 919 East Hillsdale Boulevard Foster City, Delaware 94404 United States | |
| Phone | 650 473 7700 |
| Website | geron.com |
Stock Details
| Ticker Symbol | 1GERN |
| Exchange | Borsa Italiana |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Harout Semerjian | Chief Executive Officer |
| Michelle Robertson | Chief Financial Officer |
| Dawn Schottlandt | Head of Investor Relations |